Laboratorios Farmaceuticos Rovi (ES:ROVI) has released an update.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Laboratorios Farmaceuticos Rovi reports on its third-quarter 2024 treasury stock operations under a liquidity contract with Bestinver SV, S.A., detailing trades involving over 231,000 shares purchased at an average price of 80.01 euros and over 235,000 shares sold at an average of 79.88 euros, resulting in a final securities account balance of 6,000 shares and a cash account balance of 523,209.85 euros.
For further insights into ES:ROVI stock, check out TipRanks’ Stock Analysis page.
Trending Articles:
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue